没有进展的优先事项:FDA被忽视的热带疾病券计划经过18年的时间.
Maple Goh1,2,3, Kevin Outterson2, Aaron S Kesselheim1
1Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA 02120, United States.
Health affairs scholar
|February 19, 2026
概括
对于被忽视的热带疾病 (NTDs) 的优先审查券 (PRV) 计划在很大程度上奖励了现有的疗法,而不是新的创新. 建议进行改革,将优惠券资格与公平的定价和在特有国家进行登记联系起来.
科学领域:
- 全球健康 全球健康
- 制药政策 制药政策
- 药物开发 药物开发
背景情况:
- 优先审查券 (PRV) 计划于2007年由美国国会建立,以激励对被忽视的热带疾病 (NTDs) 的药物和疫苗的开发.
- 食品和药物管理局 (FDA) 批准的符合条件的产品授予赞助商一个优惠券,以加快对另一种产品的审查.
研究的目的:
- 评估对NTDs的PRV计划对公众健康的影响.
- 分析FDA批准的时间与全球健康指标和优惠券利用有关.
主要方法:
- 审查2007年至2024年期间为NTD产品授予的所有14个优惠券.
- 分析包括FDA批准时间相对于世界卫生组织 (WHO) 预资格,基本药物清单 (EML) 的列入,以及在流行国家初次使用.
主要成果:
- 57%的获奖产品获得了世卫组织预资格,57%的产品被列入EML.
- 美国食品和药物管理局的批准发生在最初的监管批准或在特有国家使用后的8.7年的中位数.
- 在世卫组织EML纳入后,FDA批准的中位数是5.2年.
结论:
- 据报道,PRV计划似乎主要是为已建立的疗法提供监管文件的激励,而不是促进创新或加强新治疗方法的获取.
- 建议包括改革该计划,将优惠券资格与公平的定价和在特有国家的注册联系起来.
相关概念视频
Drug Regulation
3.1K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.1K
Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
24
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
24
Pharmacovigilance
1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
Prescription, Nonprescription and Orphan Drugs
1.3K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.3K
Bioequivalence studies: Biowaivers
292
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
292


